EMA: Guideline on the evaluation of drugs for the treatment of gastro-oesophageal reflux disease
14.03.2011
This guideline intends to address the EU regulatory position on the main topics of the clinical development of new medicinal products in the treatment of patients with gastro-oesophageal reflux disease (GORD).
SciencePharma
